Evidence map›Paper›PMID 30415452›Full record

ArticleRheumatology international2019

Self-reported disease severity in women with systemic lupus erythematosus.

A Dima, S Caraiola, C Delcea, R A Ionescu, C Jurcut, C Badea

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A DimaInternal Medicine Department, Carol Davila UMF, Dionisie Lupu Street 37, 020022, Bucharest S2, Romania. alina_dima@outlook.com.ORCID 0000-0001-8743-3236
S CaraiolaInternal Medicine Department, Carol Davila UMF, Dionisie Lupu Street 37, 020022, Bucharest S2, Romania.ORCID 0000-0002-7346-8427
C DelceaInternal Medicine Department, Carol Davila UMF, Dionisie Lupu Street 37, 020022, Bucharest S2, Romania.ORCID 0000-0001-7642-9290
R A IonescuInternal Medicine Department, Carol Davila UMF, Dionisie Lupu Street 37, 020022, Bucharest S2, Romania.ORCID 0000-0002-6487-8053
C JurcutDr Carol Davila Central University Emergency Military Hospital, Bucharest, Romania.ORCID 0000-0001-9613-7420
C BadeaInternal Medicine Department, Carol Davila UMF, Dionisie Lupu Street 37, 020022, Bucharest S2, Romania.ORCID 0000-0001-6992-2300
Carol Davila University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE), pathology with net feminine predominance, is one of the most complex autoimmune diseases and has major impact on patients' life. The aim is to identify patient and disease-related factors associated with self-perceived disease severity in female SLE patients. This cross-sectional study enrolled 73 women fulfilling the 2012 Systemic Lupus International Collaborating Clinic (SLICC) criteria. SLE disease activity was assessed by the Systemic Lupus Activity Measure (SLAM) score and overall damage by the SLICC/American College of Rheumatology (ACR) index. Patients' general characteristics, associated conditions as well as SLE specific clinical involvements and therapeutic principles were also noted. Fatigue was assessed by FACIT-fatigue scale. Self-perceived disease severity was assessed using numerical rating scales (1-10 NRSs), to evaluate the disease severity at inclusion (1-10 NRS now) and worst severity anytime during disease history (1-10 NRS worst ever). In regard to worst ever lupus severity, 54.8% of patients responded with 9 or 10, while none with 1 or 2 even if only 22.9% of the patients responded with 7 or more for disease severity at inclusion (1-10 NRS now). Women with higher 1-10 NRS now answers had also higher 1-10 NRS worst ever, SLAM, SLICC, and FACIT-fatigue scores. They associated more frequently anxiety/depression diagnosis, antiphospholipid syndrome, joint involvement as well as treatments with corticosteroids. Self-reported disease severity worst ever, anxiety/depression diagnosis, fatigue, and the daily dose of corticosteroids were independently associated with patients' perception on lupus severity at inclusion: OR (95% CI), 2.13 (1.15-3.94) p = 0.017, 6.67 (1.11-39.97) p = 0.038, 1.10 (1.02-1.19) p = 0.018, and 1.11 (1.02-1.21) p = 0.020, respectively. The vast majority of patients identified severe and very severe events during their disease history, results that raise awareness of burden concerning lupus occurrence in women's life. Self-perceived lupus severity is multifactorial, influenced also by factors less considered in the SLE management like fatigue and the depression/anxiety disorders, but also by the previous patient's experience.

Indexed as

Adrenal Cortex HormonesAdultAntiphospholipid SyndromeAnxiety DisordersCross-Sectional StudiesDepressive DisorderFatigueFemaleHumansLupus Erythematosus, SystemicMiddle AgedSelf ReportSeverity of Illness IndexAdrenal Cortex HormonesDisease activityFatigueSelf-rated healthSystemic lupus erythematosusWomen’s health

Identifiers

PMID30415452
OpenAlexW2900209329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.